Article Sidebar
Published:
Jun 12, 2023Keywords:
Article Details
Submission of a manuscript to this journal is a representation that the manuscript has not been published previously and is not under consideration for publication elsewhere.
All authors named in each manuscript would be required to sign a form (to be supplied by the Editor) so that they may retain their copyright in the article but to assign to us (the Publishers) and its licensees in perpetuity, in all forms, formats and media (whether known or created in the future) to (i) publish, reproduce, distribute, display and store the contribution, (ii) translate the contribution into other languages, create adaptations, reprints, include within collections and create summaries, extracts and/or abstracts of the contribution, (iii) create any other derivative works(s) based on the contribution, (iv) to exploit all subsidiary rights in the contribution, (v) the inclusion of electronic links from the contribution to third party material where-ever it may be located, and (vi) license any thrid party to do any or all of the above.
Main Article Content
Patients’ satisfaction with treatment using anti rheumatic drugs, and their adherence to medication: A non interventional, cross sectional study among some Chinese outpatients
Abstract
Purpose: To determine satisfaction with treatment and adherence to medication amongst Chinese patients with rheumatoid arthritis.
Methods: This cross-sectional study enrolled 398 rheumatoid arthritis (RA) patients who filled out questionnaire during outpatient consultation. The Chinese version of the Treatment Satisfaction Questionnaire (C-TSQM-II) was used to evaluate treatment satisfaction, while the Chinese Compliance Questionnaire for Rheumatology (threshold ≤ 80) and the medication possession ratio (MPR) were used for the assessment of adherence to medication.
Results: In all medications, treatment satisfaction was higher in the mild subgroup and the moderate subgroup than in the severe subgroup (p < 0.05). Treatment satisfaction scores with respect to biological disease-modifying anti-rheumatic drugs (bDMARDs) were significantly lower in patients in the severe subgroup than in those in the moderate subgroup, with respect to convenience and global satisfaction (p < 0.05). Moreover, for bDMARDs therapies, treatment satisfaction was higher in the moderate subgroup than in the severe subgroup in all four areas examined (p < 0.05). The Chinese Compliance Questionnaire score showed that 156 patients (39 %) were adherent to medication, while 242 patients (61 %) were not. Results from MPR indicate that 310 patients (78 %) were adherent to medication, while 68 patients (22 %) were not. In the mild group, 96.5 % of patients were adherent to all medications, and 94.4 % were adherent to bDMARDs.
Conclusion: Patients were most likely unable to distinguish amongst disease progression, disease-induced damage, and other causes of pain or discomfort. Treatment satisfaction and medication adherence were higher in patients with mild rheumatoid arthritis.
